Diabetes
Conference Coverage
SURMOUNT-2: Tirzepatide rings up major weight loss in type 2 diabetes
Taken together, results from SURMOUNT-1 and SURMOUNT-2 appear to make a good case for a weight-loss indication that will not depend on whether a...
News
Low copays drive better adherence to new diabetes drugs
Regardless of patients’ socioeconmic status, copays were related to adherence.
News
Is education or screening better for type 1 diabetes?
Despite the impressive data from the FR1DA study, not all diabetes experts are convinced that a general screening for type 1 diabetes would be...
News from the FDA/CDC
FDA OKs empagliflozin for children with type 2 diabetes
This approval represents only the second oral treatment option for children and adolescents with type 2 diabetes after metformin.
News
NAFLD increases risk for severe infections
Physicians should assess their patients’ vaccination status and seek to control modifiable risk factors, such as diabetes.
News
Hold Ozempic before surgery to optimize patient safety?
“It’s a really hot issue now. We are getting emails from our members looking for guidance.”
Conference Coverage
A ‘one-stop shop’: New guidance on hormones and aging
Part of what we need to do is [provide] the evidence that we have, which includes evidence of when not to prescribe as well as [when] to prescribe...
News
Could semaglutide treat addiction as well as obesity?
“I would say, overall, the jury is still out,” as to whether anecdotal reports of GLP-1 agonists curbing addictions will be borne out in...
News
Low-carb breakfast key to lower glucose variability in T2D?
“By making a small adjustment to the carb content of a single meal rather than the entire diet, we have the potential to increase adherence...
News
Medicaid patients with heart failure get poor follow-up after hospital discharge
Both structural racism and problems with access are likely behind the low rates of follow-up care.